rivastigmine has been researched along with Bradyarrhythmia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonge, O; Cifonelli, E; Iqbal, FM | 1 |
| Braund, V; DesLauris, C; Leikin, JB | 1 |
| Cantor, MD; Farwell, W; Hernandez, RK; Lawler, EV | 1 |
| Léos, CL; Paulison, B | 1 |
| Herrmann, N; Lanctôt, KL; Thompson, S | 1 |
| Anand, R; Graham, S; Hartman, R; Morganroth, J | 1 |
3 review(s) available for rivastigmine and Bradyarrhythmia
| Article | Year |
|---|---|
Collapse in the elderly: rivastigmine-induced heart block and a literature review of the pharmacology of acetylcholinesterase inhibitors used in Alzheimer's disease.
Topics: Accidental Falls; Aged, 80 and over; Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Female; Femoral Neck Fractures; Heart Block; Hemiarthroplasty; Humans; Pacemaker, Artificial; Rivastigmine; Treatment Outcome | 2018 |
Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bradycardia; Cholinesterase Inhibitors; Drug Interactions; Dyspnea; Electrocardiography; Female; Heart Rate; Humans; Phenylcarbamates; Rivastigmine; Syncope | 2010 |
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2004 |
1 trial(s) available for rivastigmine and Bradyarrhythmia
| Article | Year |
|---|---|
Electrocardiographic effects of rivastigmine.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bradycardia; Carbamates; Cardiovascular System; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Diseases; Heart Rate; Humans; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Tachycardia | 2002 |
3 other study(ies) available for rivastigmine and Bradyarrhythmia
| Article | Year |
|---|---|
Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
Topics: Aged; Bradycardia; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Humans; Indans; Lewy Body Disease; Male; Miosis; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine | 2014 |
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Heart Rate; Hospitals, Veterans; Humans; Incidence; Indans; Massachusetts; Nootropic Agents; Phenylcarbamates; Piperidines; Risk; Rivastigmine; Veterans | 2009 |
Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk; Rivastigmine | 2011 |